Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Camberwell, Victoria
- Most recent report
- 8-K, filed Jul 14, 2026
- Incorporated
- Delaware
- Filings on record
- 433 filings
- On EDGAR
- CIK 1517681
- Fiscal year ends
- June
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 59
News 8 of 130
- 8-K Leadership change Jul 14, 2026
- 8-K Leadership change Feb 26, 2026
- 8-K Current report on a material event Jan 7, 2026
- 8-K Current report on a material event Nov 10, 2025
- 8-K Significant contract Oct 14, 2025
- 8-K Leadership change Aug 19, 2025
- 8-K Leadership change Aug 13, 2025
- 8-K Significant contract Jul 30, 2025
Prospectuses and Registrations 8 of 74
- S-1 Registration statement for an offering Jul 17, 2026
- S-1 Registration statement for an offering Apr 10, 2026
- 424B3 Prospectus supplement for an offering Mar 6, 2026
- S-1/A Registration statement for an offering, amended Feb 19, 2026
- S-1 Registration statement for an offering Feb 2, 2026
- 424B3 Prospectus supplement for an offering Jan 30, 2026
- S-1 Registration statement for an offering Dec 30, 2025
- 424B3 Prospectus supplement for an offering Aug 18, 2025
Proxies 1
Ownership 8 of 22
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 14, 2025
- SCHEDULE 13G Large holder reported a passive stake Aug 19, 2025
- 4 Insider reported a trade Aug 23, 2023
- SC 13G Large holder reported a passive stake Sep 8, 2021
- 4 Insider reported a trade Aug 20, 2021
- 4 Insider reported a trade Aug 20, 2021
- 3 Insider reported their initial holding Aug 20, 2021
- SC 13G Large holder reported a passive stake Jul 7, 2020
Other 8 of 147
Everything here comes from Propanc Biopharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.